Literature DB >> 19787436

Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts.

Shuming Zhang1, Jun Wang, Mehmet A Bilen, Sue-Hwa Lin, Samuel I Stupp, Robert L Satcher.   

Abstract

After prostate cancer cells (PCa) arrive in bone, interactions with cells that include long bone osteoblasts (LBOB) and bone marrow stromal cells (BMSC) lead to metastasis formation. The effect of heterotypic cell-cell contact between PCa cells and BMSC or LBOB on PCa cell gene expression is poorly understood. To establish the role of heterotypic contact in bone metastasis formation, we mixed and co-cultured PC3 cells with rat BMSC, LBOB, or human prostate stromal cells (PS15). PC3 cells were then re-isolated for gene array analysis, and imaged using in situ hybridization to confirm that heterotypic contact regulates gene expression. The gene expression was examined using focused gene arrays containing 96 each of tumor metastasis genes or osteogenesis genes. A total of 18 out of 192 genes in PC3 cells were found to be under or over expressed subsequent to heterotypic contact with BMSC when analyzed. A total of 15 genes out of 192 were regulated in co-culture with LBOB, and 19 genes with PS15. Only two genes, uPA and Collagen III, were regulated by contact with BMSC or LBOB (both are bone derived cells), but not by contact with PS15. The relationship between cell-cell contact and uPA expression was further explored by varying cell ratios in co-culture. uPA over-expression in PC3 was related to the BMSC:PC3 ratio, and was maximum at a 10:1 ratio, where most PC3 cells would be in contact with BMSC, as predicted by a theoretical model of heterotypic contact. In situ staining of micropatterned PC3 and BMSC cells showed that uPA over-expression localizes to regions of heterotypic cell-cell contact. Taken together, our results suggest that heterotypic cell-to-cell contact between PC3 and BMSC proportionally enhances gene expression for uPA, providing a mechanism for localized control of invasiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787436     DOI: 10.1007/s10585-009-9289-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells.

Authors:  Danilo Millimaggi; Claudio Festuccia; Adriano Angelucci; Sandra D'Ascenzo; Nadia Rucci; Silvio Flati; Mauro Bologna; Anna Teti; Antonio Pavan; Vincenza Dolo
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

3.  Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma.

Authors:  S H Lang; N W Clarke; N J George; T D Allen; N G Testa
Journal:  Prostate       Date:  1998-02-15       Impact factor: 4.104

4.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

5.  Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.

Authors:  H Siggelkow; K Rebenstorff; W Kurre; C Niedhart; I Engel; H Schulz; M J Atkinson; M Hüfner
Journal:  J Cell Biochem       Date:  1999-10-01       Impact factor: 4.429

Review 6.  Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.

Authors:  Shian-Ying Sung; Leland W K Chung
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

Review 7.  Animal models of bone metastasis.

Authors:  Thomas J Rosol; Sarah H Tannehill-Gregg; Bruce E LeRoy; Stefanie Mandl; Christopher H Contag
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

8.  Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

Authors:  Sun-Jin Kim; Hisanori Uehara; Takashi Karashima; David L Shepherd; Jerald J Killion; Isaiah J Fidler
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531

9.  MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.

Authors:  Elisa Benasciutti; Gilles Pagès; Olga Kenzior; William Folk; Francesco Blasi; Massimo P Crippa
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies.

Authors:  C A Hart; L J Scott; S Bagley; A A G Bryden; N W Clarke; S H Lang
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

View more
  10 in total

1.  Osteogenic differentiation is synergistically influenced by osteoinductive treatment and direct cell-cell contact between murine osteoblasts and mesenchymal stem cells.

Authors:  Ming-Tzu Tsai; Dan-Jae Lin; Sherry Huang; Hsiu-Ting Lin; Walter H Chang
Journal:  Int Orthop       Date:  2011-05-13       Impact factor: 3.075

2.  The PCa Tumor Microenvironment.

Authors:  Joseph L Sottnik; Jian Zhang; Jill A Macoska; Evan T Keller
Journal:  Cancer Microenviron       Date:  2011-07-05

3.  Platelet TSP-1 controls prostate cancer-induced osteoclast differentiation and bone marrow-derived cell mobilization through TGFβ-1.

Authors:  Bethany A Kerr; Koran S Harris; Lihong Shi; Jeffrey S Willey; David R Soto-Pantoja; Tatiana V Byzova
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

4.  Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells.

Authors:  Xiang-Qing Zhu; Xing-Hua Pan; Weibo Wang; Qiang Chen; Rong-Qing Pang; Xue-Min Cai; Andrew R Hoffman; Ji-Fan Hu
Journal:  Biomaterials       Date:  2009-12-30       Impact factor: 12.479

Review 5.  Osteoblastic Factors in Prostate Cancer Bone Metastasis.

Authors:  Song-Chang Lin; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

6.  Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation.

Authors:  Tomohiro Itoh; Yuko Ito; Yoshinori Ohtsuki; Masashi Ando; Yasuyuki Tsukamasa; Nami Yamada; Tomoki Naoe; Yukihiro Akao
Journal:  J Mol Histol       Date:  2012-04-17       Impact factor: 2.611

7.  Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties.

Authors:  Raphael Lis; Cyril Touboul; Christophe M Raynaud; Joel A Malek; Karsten Suhre; Massoud Mirshahi; Arash Rafii
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms.

Authors:  Giulia Ribelli; Sonia Simonetti; Michele Iuliani; Elisabetta Rossi; Bruno Vincenzi; Giuseppe Tonini; Francesco Pantano; Daniele Santini
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

9.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

10.  Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.

Authors:  Raphael Lis; Cyril Touboul; Najeeb M Halabi; Abishek Sainath Madduri; Denis Querleu; Jason Mezey; Joel A Malek; Karsten Suhre; Arash Rafii
Journal:  J Transl Med       Date:  2014-03-05       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.